GB0706168D0 - Compounds - Google Patents
CompoundsInfo
- Publication number
- GB0706168D0 GB0706168D0 GBGB0706168.2A GB0706168A GB0706168D0 GB 0706168 D0 GB0706168 D0 GB 0706168D0 GB 0706168 A GB0706168 A GB 0706168A GB 0706168 D0 GB0706168 D0 GB 0706168D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0706168.2A GB0706168D0 (en) | 2007-03-29 | 2007-03-29 | Compounds |
PCT/EP2008/053591 WO2008119713A1 (en) | 2007-03-29 | 2008-03-27 | 1- (1-cyclohexyl-4-piperidinyl) -1, 3-dihydro-2h-benzimidazol-2-one derivatives which have activity on the m1 receptor and their use in medicine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0706168.2A GB0706168D0 (en) | 2007-03-29 | 2007-03-29 | Compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0706168D0 true GB0706168D0 (en) | 2007-05-09 |
Family
ID=38050490
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0706168.2A Ceased GB0706168D0 (en) | 2007-03-29 | 2007-03-29 | Compounds |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0706168D0 (en) |
WO (1) | WO2008119713A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8288412B2 (en) | 2005-09-30 | 2012-10-16 | Glaxo Group Limited | Compounds which have activity at M1 receptor and their uses in medicine |
EA016286B1 (en) | 2005-09-30 | 2012-03-30 | Глэксо Груп Лимитед | Compounds which have activity at mreceptor and their uses in medicine |
JP5209479B2 (en) | 2005-09-30 | 2013-06-12 | グラクソ グループ リミテッド | Benzimidazolones having activity at the M1 receptor |
GB0718415D0 (en) | 2007-09-20 | 2007-10-31 | Glaxo Group Ltd | Compounds |
AU2009324894B2 (en) | 2008-11-25 | 2015-04-09 | University Of Rochester | MLK inhibitors and methods of use |
EP2576549A4 (en) | 2010-05-24 | 2013-12-18 | Univ Rochester | Bicyclic heteroaryl kinase inhibitors and methods of use |
CN104884059B (en) | 2012-11-30 | 2018-08-10 | 罗切斯特大学 | Mixing pedigree kinase inhibitor for HIV/AIDS treatments |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU701127B2 (en) * | 1994-10-27 | 1999-01-21 | Merck & Co., Inc. | Muscarine antagonists |
GB0605785D0 (en) * | 2006-03-22 | 2006-05-03 | Glaxo Group Ltd | Compounds |
-
2007
- 2007-03-29 GB GBGB0706168.2A patent/GB0706168D0/en not_active Ceased
-
2008
- 2008-03-27 WO PCT/EP2008/053591 patent/WO2008119713A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2008119713A1 (en) | 2008-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0706793D0 (en) | Compounds | |
GB0704407D0 (en) | Compounds | |
GB0704394D0 (en) | Compounds | |
GB0705672D0 (en) | Compounds | |
GB0706173D0 (en) | Compounds | |
GB0707092D0 (en) | Compounds | |
GB0706188D0 (en) | Compounds | |
GB0706165D0 (en) | Compounds | |
GB0706168D0 (en) | Compounds | |
GB0707034D0 (en) | Compounds | |
GB0706174D0 (en) | Compounds | |
GB0706189D0 (en) | Compounds | |
GB0706187D0 (en) | Compounds | |
GB0706167D0 (en) | Compounds | |
GB0706190D0 (en) | Compounds | |
GB0706164D0 (en) | Compounds | |
GB0706170D0 (en) | Compounds | |
GB0704939D0 (en) | Compounds | |
GB0703756D0 (en) | Compounds | |
GB0701985D0 (en) | Compounds | |
GB0701986D0 (en) | Compounds | |
GB0701981D0 (en) | Compounds | |
GB0703067D0 (en) | Compounds | |
GB0702976D0 (en) | Compounds | |
GB0706929D0 (en) | Compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |